EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective effect of irbesartan against hepatic ischemia–reperfusion injury in rats: role of ERK, STAT3, and PPAR-γ inflammatory pathways in rats

Salma A El-Marasy, Rasha E Mostafa, Hoda B Mabrok, Marwa S Khattab, Sally A El Awdan

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03301-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Salma A El-Marasy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt. sa.el-marasy@nrc.sci.eg. Hauptthemen laut MEDLINE: Irbesartan, STAT3 Transcription Factor, Reperfusion Injury, PPAR gamma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Centre Egypt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to elucidate the possible hepatocellular protective role of irbesartan during hepatic ischemia–reperfusion injury (HIRI) and the probable underlying mechanisms. Wistar rats were allocated into four groups: sham; HIRI (control); irbesartan (50 mg/kg) + HIRI; irbesartan (100 mg/kg) + HIRI; irbesartan + GW9662 (1 mg/kg, i.p.) + HIRI. Rats pretreated orally with irbesartan or vehicle for 14 days underwent 45-min hepatic ischemia followed by 60-min reperfusion. Irbesartan preconditioning diminished alanine transaminase (ALT) and aspartate transaminase (AST) serum levels, and reduced extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3). Irbesartan decreased proapoptotic BAX (bcl-2-like protein 4), increased anti-apoptotic B-cell lymphoma 2 (BCL2) hepatic content, and thereby reduced BAX/BCL2 ratio. Moreover, irbesartan preconditioning reduced autophagy-related proteins Beclin1 and LC3 II, and elevated p62 (protein responsible for autophagosome degradation). It elevated proliferator-activated receptor γ (PPAR-γ), and reduced tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) hepatic gene expression. Also, hepatic protein expressions of nuclear factor kappa-B p65 (NF-κB p65) and caspase-3 were lessoned by irbesartan pretreatment in HIRI rats. However, GW9662 abrogated irbesartan's effect on HIRI. The protective effect of irbesartan on HIRI may be mediated by alleviation of ERK, STAT3, and PPAR-γ inflammatory pathways, exerting anti-apoptotic and anti-autophagic effects in HIRI in rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IrbesartanSTAT3 Transcription FactorReperfusion InjuryPPAR gammaLiverExtracellular Signal-Regulated MAP KinasesBiphenyl CompoundsAngiotensin II Type 1 Receptor BlockersAnimalsRats, WistarMaleRatsApoptosisSignal TransductionProtective Agents

Stichwörter der Autor:innen

ERKGW9662Hepatic–ischemic reperfusion injuryIrbesartanPPAR-γ inflammatory pathwaySTAT3

Substanzen

IrbesartanSTAT3 Transcription FactorStat3 protein, ratPPAR gammaExtracellular Signal-Regulated MAP KinasesBiphenyl CompoundsAngiotensin II Type 1 Receptor BlockersProtective AgentsPPAR gamma, rat

Autor:innen und Institutionen

  • Department of Pharmacology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt. sa.el-marasy@nrc.sci.eg.
  • Department of Pharmacology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt.
  • Nutrition and Food Science Department, Food Industries and Nutrition Research Institute, National Research Centre, Giza, Egypt.
  • Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.

Förderung

  • National Research Centre Egypt

Zitieren

APA

El-Marasy, S. A., Mostafa, R. E., Mabrok, H. B., Khattab, M. S., & Awdan, S. A. E. (2025). Protective effect of irbesartan against hepatic ischemia–reperfusion injury in rats: role of ERK, STAT3, and PPAR-γ inflammatory pathways in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03301-6

Vancouver

El-Marasy SA, Mostafa RE, Mabrok HB, Khattab MS, Awdan SAE. Protective effect of irbesartan against hepatic ischemia–reperfusion injury in rats: role of ERK, STAT3, and PPAR-γ inflammatory pathways in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03301-6

BibTeX
@article{ElMarasy2025,
  author = {El-Marasy, Salma A and Mostafa, Rasha E and Mabrok, Hoda B and Khattab, Marwa S and Awdan, Sally A El},
  title = {Protective effect of irbesartan against hepatic ischemia–reperfusion injury in rats: role of ERK, STAT3, and PPAR-γ inflammatory pathways in rats},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03301-6}
}
Kostenlos starten →